A carregar...
Temozolomide promotes immune escape of GBM cells via upregulating PD-L1
Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor with poor prognosis, and currently effective therapeutic strategies are still limited. Although temozolomide (TMZ) is commonly used for GBM therapy and its mechanism was well characterized, while its side effects were req...
Na minha lista:
| Publicado no: | Am J Cancer Res |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
e-Century Publishing Corporation
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6610056/ https://ncbi.nlm.nih.gov/pubmed/31285949 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|